‘Brain Fag’ Symptoms in Apprentices in NigeriaMorakinyo O.a · Peltzer K.b
aDepartment of Mental Health, College of Health Sciences, Olufemi Awolowo University, Ile-Ife, Nigeria; bHealth Behaviour Research Unit, University of the North, Sovenga, South Africa
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The ‘brain fag’ syndrome, which was first reported from West Africa in 1960 among students, has been shown to occur very widely in African students in western educational systems south of the Sahara. This study investigated the distribution of its symptoms in a group of apprentices chosen by convenient sampling from Ile-Ife, a university town about 240 km northeast of Lagos in Nigeria. The subjects who (in contrast) were training under an indigenous form of education – the African apprenticeship system – consisted of 183 (69.8%) males, and 79 (30.2%) females, in the age range of 13–26 years (mean ± SD 18.2 ± 3.0 years). Questionnaires were interview-administered to collect data on the sociodemographic, economic, and family background, English language proficiency, and the degree of the presence of brain fag symptoms. Results indicated a generally low rate of brain fag symptoms among these different types of apprentices. A relationship between proficiency in English, but not socioeconomic status, with brain fag symptoms was found. In the case of the Nigerian apprentices investigated here, brain fag symptoms were not significantly associated with the method of training learning (which is dependent mainly on verbal instructions in the vernacular from their bosses, and vicarious learning by observing the boss at work). The implications of these findings for two of the theories advanced for the pathogenesis of the brain fag syndrome were discussed.
© 2002 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.